Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
Study Details
Study Description
Brief Summary
A total of 50 eyes were analyzed (25 patients). The subjects selected were over 18 years of age. No gender distinction was made in the choice of subjects. All subjects were carriers of silicone hydrogel contact lenses. The antecedents of the eye diseases not identified, neither the previous eye surgeries nor the systemic or ocular medication. All patients read, understood and signed an informed consent form of the study.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
A study was performed using the contralateral eye, the study groups were randomized. The choice of eye for each tear was random and established as an artificial tear A and artificial tear B. The patients were not previously warned about the type of artificial tear they were going to use or the difference that existed between them, therefore, they were unaware of the benefits that such tears could offer them. The examiner did know what tear was applied to each eye.
As for the lubricants used; Tear A (Aquoral Forte®, ESTEVE®, Farmigea, Pisa, Italy) was a combination of 0.4% unridged hyaluronic acid and 0.2% Galacto-xyloglucan. The galacto-xyloglucan is extracted from the tamarind seed. It consists of 30 single doses, each with 0.5 ml and have a daily use closure, that is, it can not be used once 12 hours have passed since the dose was opened. This lubricant lacks preservatives.
On the other hand, tear B (Aquoral Lipo® [Spain] / Lumixa® [Italy], ESTEVE®, Farmigea, Pisa, Italy) is a combination of three components; cross-linked hyaluronic acid (CXL) at 0.15%, crocin and liposomes. It is an ophthalmic lubricant and antioxidant solution. Its package is 10 ml multidose, so it can be used for a long time. It is composed of liposomes, sodium salt of crosslinked hyaluronic acid 0.15%, ethylenediaminetetraacetic acid (EDTA) disodium salt and crocin. Although this tear comes in a multi-dose container, it does not contain a preservative due to the dispenser that does not let microorganisms from outside. Contact lenses can be used while both lubricants are applied. In this regard, the study patients used their silicone hydrogel contact lenses monthly during the study.
All patients in the study had a period of one month without using any type of artificial tear or eye drops. Once this time or study was over, the patients were explained how artificial tears should be instilled. The visits were carried out blindly by research optometrists. Who did not know how the distribution of artificial tears in patients had been. The artificial tears were administered 3 times a day for 6 weeks and the subjects belonging to the study underwent a clinical examination in the period prior to treatment and 45 days after the treatment, once the treatment with artificial tears. He was repeated the tests of the beginning, nevertheless, the meibografía was not realized, since the use of artificial tears was not going to cause the growth of the glands of Meibomio
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Hyaluronic Acid One drop application of Hyaluronic acid + Galact-Xyloglucan with a dosage of 3 times a day for 45 days |
Drug: Hylauronic Acid
Schirmer Test, BUT test and OSDI test. Previous and After treatment
Other Names:
|
| Experimental: CrossLinked Hyalurnic Acid One drop application of Crosslinked Hylauronic Acid + Liposomes with a dosage of 3 times a day for 45 days |
Drug: Hylauronic Acid
Schirmer Test, BUT test and OSDI test. Previous and After treatment
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Schirmer Test [6 weeks]
Measurement of the tear volume. Scale between 0 and 30 milimeters (mm) Higger is better
- Break Up Time Test [6 weeks]
Lacrimal rupture time of the lipid layer. Scale between 0 and 25 seconds (s) Higger is better
- Ocular Surface Disease Index [6 weeks]
Dry Eye Score from Questionnaire. Scale between 0 and 50 points. Higger is worse
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Ocular Surface Disease Index over 15
-
Dysfunction of the meibomian gland
-
User contact lenses silicone hydrogel
-
User of digital screens for a long timeç
Exclusion Criteria:
-
Previous eye surgeries
-
Previous eye pathologies
-
User of artificial tears
-
User of ophthalmic gels
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | José-María Sánchez-González | Sevilla | Seville | Spain | 41012 |
Sponsors and Collaborators
- University of Seville
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HyaluronicAcidClinicalTrial